Health Care Services

Aveanna Healthcare

Aveanna Healthcare released FY2026 Q1 earnings on May 14 Pre-Market EST, actual revenue USD 647.92 M (forecast USD 613.24 M), actual EPS USD 0.19 (forecast USD 0.0968)

Aveanna Healthcare to Release FY2026 Q1 Earnings on May 14 Pre-Market EST, Forecast Revenue USD 613.24 M, EPS USD 0.0968

Aveanna Healthcare released FY2025 Q4 earnings on March 19 Pre-Market (EST), actual revenue USD 662.48 M (forecast USD 649.48 M), actual EPS USD 0.8 (forecast USD 0.1464)

Aveanna Healthcare released FY2025 Annual Earnings on March 19 Pre-Market (EST), actual revenue USD 2.433 B (forecast USD 2.421 B), actual EPS USD 1.05 (forecast USD 0.3664)

Aveanna Healthcare to Release FY2025 Q4 Earnings on March 19 Pre-Market EST, Forecast Revenue USD 649.48 M, EPS USD 0.1464

Aveanna Healthcare Holdings Gains CHAP Certification to Enhance Reputation in Home Health Care

Aveanna Healthcare Holdings (AVAH) Stock Price Doubled in the Past Year

Analyst Maintains Aveanna Healthcare's Hold Rating, With a Target Price of $10

Swiss Bank Raises Aveanna Healthcare Target Price to $9.50

Aveanna Healthcare Reports Strong Q3 Earnings Growth

Aveanna Healthcare released FY2025 9 Months Earnings on November 6 Pre-Market EST, with actual revenue of USD 1.771 B and EPS of USD 0.2166

Aveanna Healthcare released FY2025 Q3 earnings on November 6 Pre-Market (EST), actual revenue USD 621.94 M (forecast USD 591.18 M), actual EPS USD 0.06 (forecast USD 0.08)

Aveanna Healthcare to Release FY2025 Q3 Earnings on November 6 Pre-Market EST, Forecast Revenue USD 591.18M, EPS USD 0.08

Aveanna Healthcare Holdings Inc. Completes Secondary Offering of 10 Million Shares

Mok CFA Analyzing Healthcare Stocks Performance

Weiss Ratings Reiterates 'Hold' Rating on Aveanna Healthcare

Aveanna Healthcare Sees 187% ROCE Growth in Five Years

Aveanna Healthcare released FY2025 Semi-Annual earnings on August 7 Pre-Market (EST), actual revenue USD 1.149 B, actual EPS USD 0.16

Aveanna Healthcare released FY2025 Q2 earnings on August 7 Pre-Market (EST), actual revenue USD 589.55 M (forecast USD 535.34 M), actual EPS USD 0.13 (forecast USD 0.0015)

Aveanna Healthcare to Release FY2025 Q2 Earnings on August 7, 2025 Pre-Market EST, Forecast Revenue USD 535.34 M, EPS USD 0.0015

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

AVAH

Aveanna Healthcare Holdings Inc. has released its 2026 financial outlook, projecting revenues of $2.56-$2.58 billion and adjusted EBITDA of $328-$332 million. The company anticipates a 9.4% annual revenue growth rate and highlights its strong national presence in pediatric homecare. Analysts rate AVAH stock as a Buy with a $9.50 price target, though concerns about high leverage and financial risk persist.

Tip Ranks

Aveanna Healthcare Issues 2026 Outlook, Highlights Growth

Aveanna's investor presentation outlines a revenue guidance of $2.56–$2.58 billion for 2026, with an adjusted EBITDA of $84.4 million for Q1 2026. Key highlights include a target gross margin of 31.7%, Q1 revenue of $647.9 million, and a balance sheet liquidity of $524.8 million. The company operates 379 locations across 39 states with 29,000 caregivers.

TradingView

Aveanna posts May 2026 investor presentation outlining $2.56-2.58B guidance and $84.4M Q1 adjusted EBITDA

Aveanna Healthcare (NASDAQ:AVAH) reported Q1 earnings of $0.18 EPS, exceeding estimates by $0.05. Revenue reached $647.92 million, up 15.9% year-over-year, surpassing expectations of $613.22 million. The company raised its 2026 revenue guidance to $2.56-$2.58 billion. Shares rose 9.9% to $7.44 following the announcement. CFO and another insider sold shares, while institutional ownership stands at 87.96%. Analysts have set a new target price of $13.00, reflecting positive sentiment towards the company's performance and outlook.

Market Beat

Invesco

Raymond James Financial

Truist Financial

Bank of Montreal

RAYMOND JAMES FINANCIAL INC 6.375%DEP SHS REP 1/40TH FXD FLTG SER B

Aveanna Healthcare (NASDAQ:AVAH) Releases Earnings Results, Beats Estimates By $0.05 EPS

BIIB

DOCS

Healthcare stocks declined on Thursday, with the NYSE Healthcare Index down 0.1%. Biogen shares fell nearly 6% after a failed Alzheimer's trial. Prestige Consumer Healthcare reported disappointing Q4 results and lowered 2026 guidance, leading to an 8% drop in shares. Doximity's shares dropped over 24% after issuing weak guidance, despite long-term growth potential. In contrast, Aveanna Healthcare shares rose 11% following strong Q1 earnings and an increased revenue forecast for 2026.

Fidelity

Biogen

Doximity

Prestige Brands

Langar Global HealthTech ETF

SPDR S&P Biotech

iShares US Healthcare Providers

iShares US Healthcare

SPDR S&P Health Equip

VG Health

iShares US Pharma

VanEck Biotech ETF

Invesco Nasdaq Biotechnology ETF

iShares Global Healthcare

Direxion S&P Biotech Bull 3X

iShares Genomics Immunology and Healthcare ETF

iShares US Medical Devices

First Trust NYSE Arca Biotech Index Fd

Invesco Biotechnology & Genome ETF

iShares Biotechnology ETF

SPDR S&P Health

Ark Genomic Revolution ETF

Global X HealthTech ETF

ALPS Medical Breakthrough

Health Care Select Sector SPDR

Proshares Ultra Nasdaq Biotech

Sector Update: Healthcare Stocks Softer Thursday Afternoon

Healthcare stocks showed mixed performance in premarket trading on Thursday. The State Street Health Care Select Sector SPDR ETF (XLV) rose by 0.2%, while the iShares Biotechnology ETF (IBB) fell by 0.1%. Aveanna Healthcare (AVAH) surged over 9% after reporting increased fiscal Q1 earnings and raising its 2026 revenue guidance. Biogen (BIIB) shares increased by more than 1% despite a phase 2 study not meeting its primary endpoint. MeiraGTx (MGTX) saw a 1% decline following a wider Q1 adjusted loss and falling revenue.

MeiraGTx

Sector Update: Healthcare Stocks Mixed Premarket Thursday

Aveanna Healthcare Holdings shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY26 sales guidance above estimates.

benzinga_article

Earnings Watch

Aveanna Healthcare | 10-Q: FY2027 Q1 Revenue Misses Estimate at USD 647.92 M

Aveanna Healthcare(AVAH.US)